Qinrui Fu

Qinrui Fu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2023 in ACS Nano
Verified
Journal Article
Closed access
DWDengshuai Wei
Dengshuai Wei
YSYong Sun
Yong Sun
HZHu Zhu
Hu Zhu
QFQinrui Fu
Qinrui Fu

2 May 2024 in ACS Nano
Verified
Journal Article
Closed access
QFQinrui Fu
Qinrui Fu
CWChuang Wei
Chuang Wei
MWMengzhen Wang
Mengzhen Wang

15 August 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZJZeyu Jiang
Zeyu Jiang
WXWenjing Xiao
Wenjing Xiao
QFQinrui Fu
Qinrui Fu

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
ZJZeyu Jiang
Zeyu Jiang
MZMeihua Zhang
Meihua Zhang
PLPeifeng Li
Peifeng Li
YWYin Wang
Yin Wang
QFQinrui Fu
Qinrui Fu
Computed tomography (CT), a diagnostic tool with clinical application, comprehensive coverage, and low cost, is used in hospitals worldwide. However, CT imaging fails to distinguish soft tissues from normal organs and tumors because their mass attenuation coefficients are similar. Various CT contrast agents have been developed in recent years to improve the sensitivity and contrast of imaging. Here, we review the progress of nanomaterial-based CT contrast agents and their applications in image-guided therapy. The CT contrast agents are classified according to their components; gold (Au)-based, bismuth (Bi)-based, lanthanide (Ln)-based, and transition metal (TM)-based nanomaterials are discussed. CT image-guided therapy of diseases, including photothermal therapy (PPT), photodynamic therapy (PDT), chemotherapy, radiotherapy (RT), gas therapy, sonodynamic therapy (SDT), immunotherapy, starvation therapy, gene therapy (GT), and microwave thermal therapy (MWTT), are reviewed. Finally, the perspectives on the CT contrast agents and their biomedical applications are discussed.

23 January 2024 in ACS Nano
Verified
Journal Article
Closed access
QFQinrui Fu
Qinrui Fu
XYXiao Yang
Xiao Yang
MWMengzhen Wang
Mengzhen Wang
KZKang Zhu
Kang Zhu
YWYin Wang
Yin Wang
JSJibin Song
Jibin Song

1 January 2023 in Theranostics
Verified
Journal Article
Open access
PDF file
XYXiao Yang
Xiao Yang
CLCongcong Li
Congcong Li
PLPeifeng Li
Peifeng Li
QFQinrui Fu
Qinrui Fu
Biosensing by optical probes is bringing about a revolution in our understanding of physiological and pathological states. Conventional optical probes for biosensing are prone to inaccurate detection results due to various analyte-independent factors that can lead to fluctuations in the absolute signal intensity. Ratiometric optical probes provide built-in self-calibration signal correction for more sensitive and reliable detection. Probes specifically developed for ratiometric optical detection have been shown to significantly improve the sensitivity and accuracy of biosensing. In this review, we focus on the advancements and sensing mechanism of ratiometric optical probes including photoacoustic (PA) probes, fluorescence (FL) probes, bioluminescence (BL) probes, chemiluminescence (CL) probes and afterglow probes. The versatile design strategies of these ratiometric optical probes are discussed along with a broad range of applications for biosensing such as sensing of pH, enzymes, reactive oxygen species (ROS), reactive nitrogen species (RNS), glutathione (GSH), metal ions, gas molecules and hypoxia factors, as well as the fluorescence resonance energy transfer (FRET)-based ratiometric probes for immunoassay biosensing. Finally, challenges and perspectives are discussed.